Search Press releases Keywords From To 17 Apr 2024 FINTEPLA[®]▼ (fenfluramine) oral solution approved in Japan for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) Read More 12 Apr 2024 Acquisition of own shares Read More 12 Apr 2024 Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY[®]▼ (romosozumab) can help to close the treatment gap in osteoporosis Read More 12 Apr 2024 UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting Read More 11 Apr 2024 Transparency notification FMR LLC Read More 5 Apr 2024 Acquisition of own shares Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
